Open Orphan continues talks over coronavirus challenge study
Open Orphan updated the market on its talks with the UK government and other partners for a coronavirus challenge study in the UK on Friday, confirming that “advanced negotiations” were ongoing.
The AIM-traded firm said no contract had been signed, however.
“The company will update the market in due course as appropriate,” the board said in its short statement.
At 1355 BST, shares in Open Orphan were up 5.68% at 27.74p.
Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news articles and we may not share the views of the author. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.